Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Rising cases of Covid infection in several countries, fear of further tightening of key policy rates by the Federal Reserve, and a growth threat of recession-like situation pose challenges for markets around the world
Biocon shares gained 3.5 percent at Rs 271 and formed long bullish candle on the daily charts with robust volumes. Also there was Morning Star kind of pattern formation, which is generally called as a bullish reversal pattern formed in an downtrend.
Sterlite Technologies has managed to traverse the key moving average of ‘200-day SMA’ (simple moving average) with some conviction after a long time, which construes a strong technical development.
The weekly expiry could keep the markets volatile as we have witnessed steady rise in open interest in 18,000 CE strike in the past few days while on the downside 17,800 PE strike has the highest open interest of more than 2,20,000 contracts which could act as immediate support from current levels.
After a short-term correction, Dr Reddy's Laboratories has formed higher bottom reversal formation. The stock is consistently taking support near the 50 and 20 day SMA (Rs 4,192, Rs 4,227)
On daily charts, IEX has formed long bullish candle which is broadly positive. But at the same time, the stock is consistently taking resistance near 20 days SMA. The medium term texture of the stock is non-directional, perhaps, traders are waiting for the either side breakout.
Fineotex Chemical is trading in an uptrend and has recently shown outperformance. The previous resistance of Rs 182 is now expected to become a support and hence any declines towards this support could be used as a buying opportunity.
Hot Stocks | The banking remains the space to track as we expect the major contribution to come from this heavyweight basket.
Hot Stocks | Malay Thakkar of GEPL Capital expects Nifty to trade in a range of 17,000-17,800. For any further upside, it is important that the index breaks and sustains above 17,750-17,800 resistance zone.
For the coming week, Ruchit Jain of 5paisa.com says 17,500 will now be seen as the important support while a move above 17,700 could again lead to a buying interest amongst market participants and take the index towards 17,900-18,000
Trade Spotlight | Here's what Mehul Kothari of Anand Rathi Shares & Stock Brokers, recommends investors should do with these stocks when the market resumes trading today
The Nifty is expected to trade in a range of 17,600–16,900 for the next few trading sessions until prices do not give any superior move on the either side of the range
A sustainable move beyond 13,780-13,800 would lead to the continuation of the move towards 14,000-14,200 levels.
Most experts say the rally is expected to continue in broader space, as both midcap and smallcap indices are still below their record highs of January 2018.
Though markets are trading with bullish bias one can stay alert near PRZ placed around 13,400-13,500 marks whereas crucial supports are standing around 12,980-13,000 levels for the coming week.
With midcaps and smallcaps expected to outperform largecaps, especially after September quarter earnings, this is the right time to build a portfolio, analysts have said.
For the rest of the week the range looks shifted towards 11,700-11,350 as of now.
Technically we believe the index is expected to swing above the upper bound of the 'Broadening formation (11,377)' & move towards 11,500 zone swiftly.
On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.
Axis Securities added ITC and CCL products in its list of top picks as it sees value buying and small cap allocation increasing, while the brokerage dropped Aarti Industries and Escorts from its list.
After some tough years, the pharma sector is performing well and is around 25 percent up while the broader market is down 20 percent year-to-date.
Experts and analysts expect a change in market leadership in the post-COVID world in which telecom, healthcare, speciality chemicals, and rural consumers may dominate other sectors.
Largecaps or sector leaders are the safest bet during a crisis because the recovery momentum generally reflects first in these stocks, say experts.
While the banks and NBFCs have been dominating the benchmark indices, market experts say emerging sectors such as pharma are gearing up to take the front seat.
The panic created by COVID-19 has taken a heavy toll on most sectors but pharma companies seem to have withstood the carnage, with some stocks delivering healthy returns during this period.